Labeler · US market

Tris Pharma Inc

Tris Pharma Inc is a US drug labeler with US FDA registrations covering 6 drug concepts (6 currently active) across 20 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes27808

Active drugs6

Registrations20 active / 20

Packages20

Sole supplier of0 drugs

Portfolio6 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Pregabalin capsule	rx	7	7	SUPPLYING
Paliperidone tablet, extended release	rx	4	4	SUPPLYING
Lacosamide tablet	rx	4	4	SUPPLYING
Potassium Chloride solution	rx	2	2	SUPPLYING
Febuxostat tablet	rx	2	2	SUPPLYING
Cyproheptadine Hydrochloride syrup	rx	1	1	SUPPLYING

At a glance

TypeLabeler
Labeler codes27808
Filing names1
Drugs (active)6
Drugs (all time)6
US registrations20
Packages20

Recent events

Shortages, recalls, and registration changes across all filing names.

Jul 11, 2019
RECALLRecall (Class II): Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bi…
Jan 15, 2019
RECALLRecall (Class II): Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Ber…
Jan 15, 2019
RECALLRecall (Class II): infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL…
Jan 15, 2019
RECALLRecall (Class II): Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Ber…
Nov 26, 2018
RECALLRecall (Class II): Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye-Free Non-Staining Berr…
Nov 26, 2018
RECALLRecall (Class II): Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Ber…
Nov 26, 2018
RECALLRecall (Class II): infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 …
Jun 15, 2017
RECALLRecall (Class II): Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bottle containing 30 mL with an oral syrin…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.